Back to search

National and Kapodistrian University of Athens

Οι επιδράσεις της χορήγησης του ευαισθητοποιητή ασβεστίου- Levosimendan- κατά την περιεγχειρητική περίοδο, σε υψηλού κινδύνου ασθενείς που υποβάλλονται σε μη καρδιοχειρουργικές επεμβάσεις

Abstract

dc:description

OBJECTIVE: Preoperative optimization of hemodynamic and tissue oxygenation parameters in high-risk surgical patients significantly decreases perioperative and immediate postoperative morbidity and mortality. Preoperative optimization of cardiac failure (CF) patients undergoing non-cardiac surgery is of utmost importance. Furthermore, levosimendan is a novel inotropic agent with proved efficacy in increasing cardiac output during episodes of acute or decompensated heart failure. Based on the abovementioned facts, this study investigates the effects of preoperative levosimendan infusion on the immediate preoperative and postoperative hemodynamic and oxygenation parameters on chronic heart failure patients scheduled to undergo non-cardiac surgical procedures. METHODS: Twenty consecutive chronic heart failure patients with ejection fraction <35% scheduled to undergo non-cardiac surgery entered the study. Patients were randomised in 1:1 ratio to receive either levosimendan or placebo. After pulmonary artery catheterization, they received a 24-hour drug infusion initiated with a loading dose of 24μg/Kg over 10 minutes, followed by a 24-hour continuous infusion of 0.1μg/Kg per minute, at the end of which they were operated. Appropriate withdrawal criteria were instituted, whereas during the levosimendan infusion period and at least for 48 hours postoperatively the patients were in close hemodynamic monitoring in the intensive care unit setting. Echocardiography was performed before infusion and on the 7th post-infusion day. RESULTS: The levosimendan infusion was well tolerated with no major cardiovascular events and without the need to withdraw any of the patients from the study. Significant increases of cardiac index, oxygen delivery and oxygen consumption were achieved in levosimendan group prior to the scheduled surgical procedure and remained elevated for at least 48 hours postoperatively compared with the placebo group. Ejection fraction was also significantly increased on the 7th post-levosimendan day compared with the placebo group. Three patients of the placebo group and no patient of the levosimedan group received inotrope postoperatively due to decompensation of the heart failure. CONCLUSIONS: Levosimendan successfully increased the hemodynamic and oxygenation status of this high-risk group of heart failure patients before the scheduled surgical procedure. Furthermore, this optimization carried on during the immediate postoperative period, when surgical stress and increased oxygen demand were still present.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kapralou, Athina
  • Καπράλου, Αθηνά

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/23690

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kapralou, Athina; Καπράλου, Αθηνά. Οι επιδράσεις της χορήγησης του ευαισθητοποιητή ασβεστίου- Levosimendan- κατά την περιεγχειρητική περίοδο, σε υψηλού κινδύνου ασθενείς που υποβάλλονται σε μη καρδιοχειρουργικές επεμβάσεις. National and Kapodistrian University of Athens, 2009. http://hdl.handle.net/10442/hedi/23690